Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsSEC EDGAR SCHEDULE 13GFiled 3 h ago

iBio, Inc.: Frazier Life Sciences Public Fund, L.P. amends Schedule 13G stake filing

Open the sourceReported by SEC EDGAR SCHEDULE 13G, sec.gov, 16 November 2026, by SEC EDGAR SCHEDULE 13G

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

Frazier Life Sciences Public Fund, L.P. amended its Schedule 13G stake filing for iBio, Inc., per SEC accession 0001231919-26-001582. The amendment updates the fund's reported ownership position in the biotech, though the filing summary disclosed no revised share count or percentage. Investors will watch for the full filing details to gauge whether Frazier's position increased, decreased or was unchanged.

Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.

Named in this story

iBio, Inc., Frazier Life Sciences Public Fund, L.P.